FI862631A0 - Process for the preparation of a therapeutically useful membrane anchor active substance conjugate - Google Patents
Process for the preparation of a therapeutically useful membrane anchor active substance conjugateInfo
- Publication number
- FI862631A0 FI862631A0 FI862631A FI862631A FI862631A0 FI 862631 A0 FI862631 A0 FI 862631A0 FI 862631 A FI862631 A FI 862631A FI 862631 A FI862631 A FI 862631A FI 862631 A0 FI862631 A0 FI 862631A0
- Authority
- FI
- Finland
- Prior art keywords
- active ingredient
- preparation
- active substance
- therapeutically useful
- membrane anchor
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
- C07K17/02—Peptides being immobilised on, or in, an organic carrier
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6018—Lipids, e.g. in lipopeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Conjugates are described in which the active ingredient is covalently bonded to the anchoring membrane, which is a compound of the formulae <IMAGE> in which A can be: sulphur, oxygen, disulphide (-S-S-), methylene (-CH2-) or -NH-; n = 0 to 5; m = 1 or 2; C* = an asymmetric carbon atom of R or S configuration, R, R' and R'' are identical or different and are an alkyl, alkenyl or alkynyl group having 7 to 25 carbon atoms or are hydrogen which can optionally be substituted by hydroxyl, amino, oxo, acyl, alkyl or cycloalkyl groups and R1 and R2 are identical or different and are defined as R, R' or R'' or can be -OR, -OCOR, -COOR, -NHCOR or -CONHR and X is an active ingredient or a spacer active ingredient group. The anchoring membrane active ingredient conjugates increase antibody formation.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3522512 | 1985-06-24 | ||
DE3522512 | 1985-06-24 | ||
DE19853546150 DE3546150A1 (en) | 1985-06-24 | 1985-12-27 | MEMBRANE ANCHOR ACTIVE CONJUGATE, ITS PRODUCTION AND USE |
DE3546150 | 1985-12-27 |
Publications (4)
Publication Number | Publication Date |
---|---|
FI862631A0 true FI862631A0 (en) | 1986-06-19 |
FI862631A FI862631A (en) | 1986-12-25 |
FI94419B FI94419B (en) | 1995-05-31 |
FI94419C FI94419C (en) | 1995-09-11 |
Family
ID=25833375
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI862631A FI94419C (en) | 1985-06-24 | 1986-06-19 | Method for preparing a therapeutically useful membrane anchor-drug conjugate |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0210412B1 (en) |
JP (1) | JP2594259B2 (en) |
KR (1) | KR930008091B1 (en) |
AT (1) | ATE131491T1 (en) |
AU (1) | AU611385B2 (en) |
CA (1) | CA1340656C (en) |
DE (2) | DE3546150A1 (en) |
DK (1) | DK172399B1 (en) |
ES (1) | ES8801677A1 (en) |
FI (1) | FI94419C (en) |
NO (1) | NO174207C (en) |
PT (1) | PT82826B (en) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3813821A1 (en) * | 1988-04-22 | 1989-11-02 | Hoechst Ag | SYNTHETIC VACCINE AGAINST MOUTH AND CLAUS DISEASE AND METHOD FOR THEIR PRODUCTION |
US6074650A (en) * | 1985-06-24 | 2000-06-13 | Hoechst Aktiengesellschaft | Membrane anchor/active compound conjugate, its preparation and its uses |
US6024964A (en) * | 1985-06-24 | 2000-02-15 | Hoechst Aktiengesellschaft | Membrane anchor/active compound conjugate, its preparation and its uses |
DE3937412A1 (en) * | 1989-11-10 | 1991-05-16 | Hoechst Ag | SYNTHETIC VACCINE FOR THE SPECIFIC INDUCTION OF CYTOTOXIC T-LYMPHOZYTES |
CA1331355C (en) * | 1986-04-21 | 1994-08-09 | Bioenterprises Pty. Ltd | Immunopotentation |
AU619443B2 (en) * | 1986-04-21 | 1992-01-30 | Bioenterprises Pty. Ltd. | Immunopotentiation |
JPS63107742A (en) * | 1986-05-20 | 1988-05-12 | Wako Pure Chem Ind Ltd | Novel functional liposome and its preparation |
DE3700173A1 (en) * | 1987-01-05 | 1988-07-14 | Hoechst Ag | METHOD FOR PRODUCING LIPOPHILE AMINO ACID DERIVATIVES AND LIPOPHILE AMINO ACID DERIVATIVES |
US5976839A (en) * | 1987-03-13 | 1999-11-02 | Bioenterprises Pty Limited | Immunopotentiation through covalent linkage between immunogen and immunopotentiating molecules |
GB2217319A (en) * | 1988-04-19 | 1989-10-25 | Synpharm Ltd | Racemic and optically active fatty amino acids, their homo- abd hetero-oligomers and conjugates, the process of their production, their pharmaceutical composi |
US5120829A (en) * | 1989-03-20 | 1992-06-09 | La Jolla Cancer Research Foundation | Hydrophobic attachment site for adhesion peptides |
JP2640293B2 (en) * | 1990-05-30 | 1997-08-13 | ドイチエス クレープスフオルシユングスツエントルム ステイフツング デス アフエントリヒエン レヒトス | Polyether-substituted antitumor agent |
DE4119856A1 (en) * | 1991-06-17 | 1992-12-24 | Hoechst Ag | N-ACYL-S- (2-HYDROXYALKYL) -CYSTEINS, THE PRODUCTION AND USE THEREOF AS INTERMEDIATE PRODUCTS FOR THE PRODUCTION OF SYNTHETIC IMMUNE ADJUVANTS AND SYNTHETIC VACCINANTS |
AU666789B2 (en) * | 1992-12-28 | 1996-02-22 | Takeda Chemical Industries Ltd. | 2-amino-6,7-dihydroxy-4-thiaheptanoic acid derivatives, production and use thereof |
EP0604945A1 (en) * | 1992-12-28 | 1994-07-06 | Takeda Chemical Industries, Ltd. | TAN-1511, its derivatives, production and use thereof |
DE4325317C2 (en) * | 1993-07-29 | 1998-05-20 | Univ Dresden Tech | Process for the radioactive labeling of immunoglobulins |
DE4329309A1 (en) * | 1993-08-31 | 1995-03-09 | Rapp Polymere Gmbh | Lipopeptide compounds |
EP0641776A3 (en) * | 1993-09-08 | 1997-05-02 | Takeda Chemical Industries Ltd | Thioglycerol derivatives. |
FR2727117A1 (en) * | 1994-11-18 | 1996-05-24 | Geffard Michel | USE OF POLYLYSIN CONJUGATES FOR THE PREPARATION OF MEDICAMENTS USEFUL IN THE TREATMENT OF NEURODEGENERATIVE DISEASES AND DEGENERATIVE DISORDERS OF AUTOIMMUN CHARACTER |
US6117940A (en) * | 1997-10-17 | 2000-09-12 | Mjalli; Adnan M. M. | Amino-ketone solid support templates |
IL125908A (en) | 1998-08-24 | 2005-05-17 | Nst Neurosurvival Technologies | Peptides and pharmaceutical compositions comprising same |
IL131266A0 (en) * | 1999-08-05 | 2001-01-28 | N S T Neurosurvival Technologi | Peptides and pharmaceutical compositions comprising same |
GB9915074D0 (en) * | 1999-06-28 | 1999-08-25 | Cortecs Plc | Ligand-binding composition |
DE102009034779A1 (en) | 2009-07-25 | 2011-02-03 | Emc Microcollections Gmbh | Synthetic analogues of bacterial lipopeptides and their application for the therapy and prophylaxis of allergic diseases |
EA023725B1 (en) * | 2010-03-23 | 2016-07-29 | Новартис Аг | Compounds (cystein based lipopeptides) and compositions as tlr2 agonists used for treating infections, inflammations, respiratory diseases etc. |
DE102011018499A1 (en) | 2011-04-23 | 2012-10-25 | Emc Microcollections Gmbh | Topical nanoparticle vaccine for the immune stimulation of dendritic cells in the skin |
US10766928B2 (en) | 2012-10-05 | 2020-09-08 | The University Of Kansas | Targeted conformationally-constrained kinked endosomal disrupting peptides |
US9701715B2 (en) * | 2012-10-05 | 2017-07-11 | The University Of Kansas | Conformationally-constrained kinked endosomal-disrupting peptides |
KR20160147960A (en) | 2014-04-25 | 2016-12-23 | 아지노모토 가부시키가이샤 | Immunostimulating agent |
DE102016005550A1 (en) | 2016-05-09 | 2017-11-09 | Emc Microcollections Gmbh | Adjuvant for the induction of a cellular immune response |
TWI762706B (en) | 2017-08-24 | 2022-05-01 | 丹麥商諾佛 儂迪克股份有限公司 | Glp-1 compositions and uses thereof |
BR112022013795A2 (en) | 2020-02-18 | 2022-09-13 | Novo Nordisk As | LIQUID PHARMACEUTICAL COMPOSITION AND KIT |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0000330B1 (en) * | 1977-06-20 | 1981-08-05 | Ciba-Geigy Ag | Lipopeptides, process for their preparation and pharmaceutical compositions containing them |
US4125569A (en) | 1977-08-25 | 1978-11-14 | Mobil Oil Corporation | Process for increasing hydrogenation rate of polymerized n-alphaolefins |
EP0014815A3 (en) * | 1978-12-20 | 1980-10-29 | Ciba-Geigy Ag | Peptide derivatives, process for their preparation and intermediates, and pharmaceutical compositions containing one of these compounds |
ATE67769T1 (en) | 1983-01-25 | 1991-10-15 | Ciba Geigy Ag | NEW PEPTIDE DERIVATIVES. |
-
1985
- 1985-12-27 DE DE19853546150 patent/DE3546150A1/en not_active Withdrawn
-
1986
- 1986-06-19 AT AT86108324T patent/ATE131491T1/en not_active IP Right Cessation
- 1986-06-19 EP EP86108324A patent/EP0210412B1/en not_active Expired - Lifetime
- 1986-06-19 DE DE3650448T patent/DE3650448D1/en not_active Expired - Lifetime
- 1986-06-19 FI FI862631A patent/FI94419C/en not_active IP Right Cessation
- 1986-06-23 DK DK294086A patent/DK172399B1/en not_active IP Right Cessation
- 1986-06-23 PT PT82826A patent/PT82826B/en unknown
- 1986-06-23 CA CA000512181A patent/CA1340656C/en not_active Expired - Fee Related
- 1986-06-23 JP JP61145031A patent/JP2594259B2/en not_active Expired - Lifetime
- 1986-06-23 AU AU58943/86A patent/AU611385B2/en not_active Expired
- 1986-06-23 ES ES556417A patent/ES8801677A1/en not_active Expired
- 1986-06-23 NO NO862511A patent/NO174207C/en not_active IP Right Cessation
- 1986-06-24 KR KR8605055A patent/KR930008091B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE3650448D1 (en) | 1996-01-25 |
EP0210412A3 (en) | 1990-02-07 |
NO862511L (en) | 1986-12-29 |
KR870000359A (en) | 1987-02-18 |
AU611385B2 (en) | 1991-06-13 |
FI94419C (en) | 1995-09-11 |
JPS6263600A (en) | 1987-03-20 |
DK294086A (en) | 1986-12-25 |
AU5894386A (en) | 1987-01-08 |
KR930008091B1 (en) | 1993-08-25 |
DK172399B1 (en) | 1998-05-18 |
NO174207B (en) | 1993-12-20 |
JP2594259B2 (en) | 1997-03-26 |
ES556417A0 (en) | 1988-02-16 |
DE3546150A1 (en) | 1987-01-22 |
PT82826B (en) | 1989-01-17 |
FI94419B (en) | 1995-05-31 |
FI862631A (en) | 1986-12-25 |
EP0210412B1 (en) | 1995-12-13 |
ATE131491T1 (en) | 1995-12-15 |
EP0210412A2 (en) | 1987-02-04 |
NO174207C (en) | 1994-03-30 |
CA1340656C (en) | 1999-07-20 |
PT82826A (en) | 1986-07-01 |
ES8801677A1 (en) | 1988-02-16 |
NO862511D0 (en) | 1986-06-23 |
DK294086D0 (en) | 1986-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI862631A0 (en) | Process for the preparation of a therapeutically useful membrane anchor active substance conjugate | |
OA08182A (en) | New peptide derivatives with a nitrogenous polycyclic structure, their method of preparation and the pharmaceutical compositions which contain them. | |
FI905575A0 (en) | NY POLYPEPTIDFOERENING OCH FOERFARANDE FOER DESS FRAMSTAELLNING. | |
SE8305535D0 (en) | PHARMACEUTICAL PREPARATION WITH ANTINICOTIC EFFECTS AND PROCEDURES FOR PREPARING THEREOF | |
FI893750A0 (en) | The method produces a therapeutically active macrocyclic derivative | |
DE68909139D1 (en) | FR901228 substance and its preparation. | |
DE3650265D1 (en) | Macrolide antibiotics and process for their preparation. | |
FR2649110B1 (en) | NOVEL PEPTIDE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
NO178923C (en) | Analogous Process for Preparation of Therapeutically Active 24-Homo Vitamin D Derivatives | |
KR890014098A (en) | Prophylaxis and treatment of central neurodegenerative diseases containing catechol amine derivatives | |
ES506284A0 (en) | A PROCEDURE FOR THE PREPARATION OF ACIDS 1, CARBADESTIAPEN-2-EM-3-CARBOXILILOS 2- AND 6- SUBSTITUTED. | |
FR2660657B1 (en) | NOVEL 3-AMINOCHROMANE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
ATE27270T1 (en) | THIOESTER OF ACETYLSALICYLIC ACID, A PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
ES2040294T3 (en) | NEW SULFUR COMPOUNDS, PROCEDURES FOR ITS PREPARATION, AS WELL AS MEDICINES. | |
SE8303913D0 (en) | Heterocyclic Associations | |
FR2597097B1 (en) | BENZOTHIAZEPINE-1, 5 DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION | |
FR2669030B1 (en) | NEW IMIDAZOLE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
KR910015301A (en) | Treatment of Sleep Apnea | |
FR2639944B1 (en) | NEW INDOLE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
ATE43594T1 (en) | 3-ALKOXY-2-(N-PYRROLIDINO)-N-PYRIDYL-N-FURYL(OD R THIENYL)-METHYL-PROPYLAMINE, THEIR PREPARATION AND PHARMACEUTICAL AGENTS CONTAINING THEM. | |
ES8401966A1 (en) | New cyanoguanidines, method for obtaining them and pharmaceutical compositions containing them. | |
KR880007502A (en) | Novel aminoalkanoyl-dibenzo [d, g] [1,3,6] dioxazosin and its preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB | Publication of examined application | ||
FG | Patent granted |
Owner name: AVENTIS PHARMA DEUTSCHLAND GMBH |
|
PC | Transfer of assignment of patent |
Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH Free format text: SANOFI-AVENTIS DEUTSCHLAND GMBH |
|
MA | Patent expired |